α-Adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with α-adrenoceptor antagonists

By Andersson Karl-Erik  

World Journal of Urology, Vol. 19, Iss. 6, 2002-04 ,pp. : 390-396

Springer Publishing Company

Access to resources Recommend Favorite

Benign prostatic hyperplasia mimicking bladder tumor

By Hsu T.H.   Matin S.F.  

Urology, Vol. 57, Iss. 6, 2001-06 ,pp. : 1166-1166

Elsevier

Access to resources Recommend Favorite

A comparison of four different α1-blockers in benign prostatic hyperplasia patients with and without diabetes

By Bozlu Murat   Ulusoy Ercüment   Çayan Selahittin   Akbay Esen   Görür Sadık   Akbay Erdem  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 5, 2004-11 ,pp. : 391-395

Informa Healthcare

Access to resources Recommend Favorite

Nonsurgical management of benign prostatic hyperplasia in men with bladder calculi

By O'Connor R.C.   Laven B.A.   Bales G.T.   Gerber G.S.  

Urology, Vol. 60, Iss. 2, 2002-08 ,pp. : 288-291

Elsevier

Access to resources Recommend Favorite

Caspases are involved in benign prostatic hyperplasia (BPH) induced apoptosis by finasteride

By Bozec A.   Ruffion A.   Decaussin M.   Devonec M.   Benahmed M.   Mauduit C.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 85-85

Elsevier

Access to resources Recommend Favorite